Phase 2 Dyskinesia Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Tardive Dyskinesia
Neurocrine Biosciences100 enrolled6 locationsNCT07365462
Recruiting
Phase 2
Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia
Biliary DyskinesiaChronic Cholecystitis
Valenta Pharm JSC300 enrolled17 locationsNCT06842966
Recruiting
Phase 1Phase 2
Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia
Tardive Dyskinesia (TD)
Luye Pharma Group Ltd.120 enrolled1 locationNCT06731868